CEO: Helen I. Torley

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Halozyme Therapeutics Inc is a biotechnology company. It is engaged in research on human enzymes that alter the extracellular matrix and tumor environment.


Key numbers

Market Capitalization:2771071400
Shares Outstanding: 146540000
Float: 137384180.79999998
Next Earning Date:2020-02-26
TTm EPS: -0.2741
TTm Dividend Rate:
200 days moving average:16.29
50 days moving average: 16.02
One day percent Change: 1.21



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,